List of Tables
Table 1. Global Human Intestinal Organoid Culture Medium Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Human Intestinal Organoid Culture Medium Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Human Intestinal Organoid Culture Medium Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Intestinal Organoid Culture Medium Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Human Intestinal Organoid Culture Medium Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (L)
Table 7. Global Human Intestinal Organoid Culture Medium Sales by Region (2020-2025) & (L)
Table 8. Global Human Intestinal Organoid Culture Medium Sales by Region (2026-2031) & (L)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Human Intestinal Organoid Culture Medium Sales by Manufacturers (2020-2025) & (L)
Table 11. Global Human Intestinal Organoid Culture Medium Sales Share by Manufacturers (2020-2025)
Table 12. Global Human Intestinal Organoid Culture Medium Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Human Intestinal Organoid Culture Medium Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Human Intestinal Organoid Culture Medium by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Intestinal Organoid Culture Medium as of 2024)
Table 16. Global Human Intestinal Organoid Culture Medium Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Human Intestinal Organoid Culture Medium Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/L)
Table 18. Key Manufacturers Human Intestinal Organoid Culture Medium Manufacturing Base and Headquarters
Table 19. Global Human Intestinal Organoid Culture Medium Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Human Intestinal Organoid Culture Medium Sales by Type (2020-2025) & (L)
Table 23. Global Human Intestinal Organoid Culture Medium Sales by Type (2026-2031) & (L)
Table 24. Global Human Intestinal Organoid Culture Medium Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Human Intestinal Organoid Culture Medium Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Human Intestinal Organoid Culture Medium ASP by Type (2020-2031) & (US$/L)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Human Intestinal Organoid Culture Medium Sales by Application (2020-2025) & (L)
Table 29. Global Human Intestinal Organoid Culture Medium Sales by Application (2026-2031) & (L)
Table 30. Human Intestinal Organoid Culture Medium High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Human Intestinal Organoid Culture Medium Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Human Intestinal Organoid Culture Medium Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Human Intestinal Organoid Culture Medium ASP by Application (2020-2031) & (US$/L)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Human Intestinal Organoid Culture Medium Growth Accelerators and Market Barriers
Table 37. North America Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Human Intestinal Organoid Culture Medium Sales (L) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Human Intestinal Organoid Culture Medium Growth Accelerators and Market Barriers
Table 40. Europe Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Human Intestinal Organoid Culture Medium Sales (L) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Human Intestinal Organoid Culture Medium Sales (L) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Human Intestinal Organoid Culture Medium Growth Accelerators and Market Barriers
Table 45. Southeast Asia Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Human Intestinal Organoid Culture Medium Investment Opportunities and Key Challenges
Table 47. Central and South America Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Human Intestinal Organoid Culture Medium Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Human Intestinal Organoid Culture Medium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Scientific Corporation Information
Table 51. Thermo Fisher Scientific Description and Major Businesses
Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Scientific Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher Scientific Human Intestinal Organoid Culture Medium SWOT Analysis
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. STEMCELL Technologies Corporation Information
Table 60. STEMCELL Technologies Description and Major Businesses
Table 61. STEMCELL Technologies Product Models, Descriptions and Specifications
Table 62. STEMCELL Technologies Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 63. STEMCELL Technologies Sales Value Proportion by Product in 2024
Table 64. STEMCELL Technologies Sales Value Proportion by Application in 2024
Table 65. STEMCELL Technologies Sales Value Proportion by Geographic Area in 2024
Table 66. STEMCELL Technologies Human Intestinal Organoid Culture Medium SWOT Analysis
Table 67. STEMCELL Technologies Recent Developments
Table 68. Merck Corporation Information
Table 69. Merck Description and Major Businesses
Table 70. Merck Product Models, Descriptions and Specifications
Table 71. Merck Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 72. Merck Sales Value Proportion by Product in 2024
Table 73. Merck Sales Value Proportion by Application in 2024
Table 74. Merck Sales Value Proportion by Geographic Area in 2024
Table 75. Merck Human Intestinal Organoid Culture Medium SWOT Analysis
Table 76. Merck Recent Developments
Table 77. bioGenous Corporation Information
Table 78. bioGenous Description and Major Businesses
Table 79. bioGenous Product Models, Descriptions and Specifications
Table 80. bioGenous Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 81. bioGenous Sales Value Proportion by Product in 2024
Table 82. bioGenous Sales Value Proportion by Application in 2024
Table 83. bioGenous Sales Value Proportion by Geographic Area in 2024
Table 84. bioGenous Human Intestinal Organoid Culture Medium SWOT Analysis
Table 85. bioGenous Recent Developments
Table 86. AimingMed Corporation Information
Table 87. AimingMed Description and Major Businesses
Table 88. AimingMed Product Models, Descriptions and Specifications
Table 89. AimingMed Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 90. AimingMed Sales Value Proportion by Product in 2024
Table 91. AimingMed Sales Value Proportion by Application in 2024
Table 92. AimingMed Sales Value Proportion by Geographic Area in 2024
Table 93. AimingMed Human Intestinal Organoid Culture Medium SWOT Analysis
Table 94. AimingMed Recent Developments
Table 95. K2 Oncology Corporation Information
Table 96. K2 Oncology Description and Major Businesses
Table 97. K2 Oncology Product Models, Descriptions and Specifications
Table 98. K2 Oncology Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 99. K2 Oncology Recent Developments
Table 100. Yeasen Biotechnology Corporation Information
Table 101. Yeasen Biotechnology Description and Major Businesses
Table 102. Yeasen Biotechnology Product Models, Descriptions and Specifications
Table 103. Yeasen Biotechnology Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 104. Yeasen Biotechnology Recent Developments
Table 105. Xiamen Mogengel Corporation Information
Table 106. Xiamen Mogengel Description and Major Businesses
Table 107. Xiamen Mogengel Product Models, Descriptions and Specifications
Table 108. Xiamen Mogengel Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 109. Xiamen Mogengel Recent Developments
Table 110. D1Med Corporation Information
Table 111. D1Med Description and Major Businesses
Table 112. D1Med Product Models, Descriptions and Specifications
Table 113. D1Med Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 114. D1Med Recent Developments
Table 115. Shang Hai OneTar Biomedicine Corporation Information
Table 116. Shang Hai OneTar Biomedicine Description and Major Businesses
Table 117. Shang Hai OneTar Biomedicine Product Models, Descriptions and Specifications
Table 118. Shang Hai OneTar Biomedicine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 119. Shang Hai OneTar Biomedicine Recent Developments
Table 120. HUAYI REGENERATION Corporation Information
Table 121. HUAYI REGENERATION Description and Major Businesses
Table 122. HUAYI REGENERATION Product Models, Descriptions and Specifications
Table 123. HUAYI REGENERATION Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 124. HUAYI REGENERATION Recent Developments
Table 125. Bio-Techne Corporation Information
Table 126. Bio-Techne Description and Major Businesses
Table 127. Bio-Techne Product Models, Descriptions and Specifications
Table 128. Bio-Techne Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 129. Bio-Techne Recent Developments
Table 130. Mingaobio Corporation Information
Table 131. Mingaobio Description and Major Businesses
Table 132. Mingaobio Product Models, Descriptions and Specifications
Table 133. Mingaobio Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 134. Mingaobio Recent Developments
Table 135. MBL Life Sience Corporation Information
Table 136. MBL Life Sience Description and Major Businesses
Table 137. MBL Life Sience Product Models, Descriptions and Specifications
Table 138. MBL Life Sience Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 139. MBL Life Sience Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Intestinal Organoid Culture Medium Product Picture
Figure 2. Global Human Intestinal Organoid Culture Medium Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Small Intestine Product Picture
Figure 4. Colon Product Picture
Figure 5. Others Product Picture
Figure 6. Global Human Intestinal Organoid Culture Medium Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Scientific Research
Figure 8. Clinical
Figure 9. R&D
Figure 10. Human Intestinal Organoid Culture Medium Report Years Considered
Figure 11. Global Human Intestinal Organoid Culture Medium Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 13. Global Human Intestinal Organoid Culture Medium Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Human Intestinal Organoid Culture Medium Revenue Market Share by Region (2020-2031)
Figure 15. Global Human Intestinal Organoid Culture Medium Sales (2020-2031) & (L)
Figure 16. Global Human Intestinal Organoid Culture Medium Sales (CAGR) by Region (2020-2031) (L)
Figure 17. Global Human Intestinal Organoid Culture Medium Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Human Intestinal Organoid Culture Medium Sales Volume Market Share in 2024
Figure 19. Global Human Intestinal Organoid Culture Medium Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Small Intestine Revenue Market Share by Manufacturer in 2024
Figure 22. Colon Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Human Intestinal Organoid Culture Medium Sales Market Share by Type (2020-2031)
Figure 25. Global Human Intestinal Organoid Culture Medium Revenue Market Share by Type (2020-2031)
Figure 26. Global Human Intestinal Organoid Culture Medium Sales Market Share by Application (2020-2031)
Figure 27. Global Human Intestinal Organoid Culture Medium Revenue Market Share by Application (2020-2031)
Figure 28. North America Human Intestinal Organoid Culture Medium Sales YoY (2020-2031) & (L)
Figure 29. North America Human Intestinal Organoid Culture Medium Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) in 2024
Figure 31. North America Human Intestinal Organoid Culture Medium Sales Volume (L) by Type (2020- 2031)
Figure 32. North America Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Human Intestinal Organoid Culture Medium Sales Volume (L) by Application (2020-2031)
Figure 34. North America Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Human Intestinal Organoid Culture Medium Sales YoY (2020-2031) & (L)
Figure 39. Europe Human Intestinal Organoid Culture Medium Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) in 2024
Figure 41. Europe Human Intestinal Organoid Culture Medium Sales Volume (L) by Type (2020-2031)
Figure 42. Europe Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Human Intestinal Organoid Culture Medium Sales Volume (L) by Application (2020-2031)
Figure 44. Europe Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 46. France Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Human Intestinal Organoid Culture Medium Sales YoY (2020-2031) & (L)
Figure 51. Asia-Pacific Human Intestinal Organoid Culture Medium Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Human Intestinal Organoid Culture Medium Sales Volume (L) by Type (2020- 2031)
Figure 54. Asia-Pacific Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Human Intestinal Organoid Culture Medium Sales Volume (L) by Application (2020-2031)
Figure 56. Asia-Pacific Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 61. India Human Intestinal Organoid Culture Medium Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Human Intestinal Organoid Culture Medium Sales YoY (2020-2031) & (L)
Figure 63. Central and South America Human Intestinal Organoid Culture Medium Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Human Intestinal Organoid Culture Medium Sales Volume (L) by Type (2021-2031)
Figure 66. Central and South America Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Human Intestinal Organoid Culture Medium Sales Volume (L) by Application (2020-2031)
Figure 68. Central and South America Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Human Intestinal Organoid Culture Medium Sales YoY (2020-2031) & (L)
Figure 72. Middle East and Africa Human Intestinal Organoid Culture Medium Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Human Intestinal Organoid Culture Medium Sales Volume (L) by Type (2021-2031)
Figure 75. South America Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Human Intestinal Organoid Culture Medium Sales Volume (L) by Application (2020-2031)
Figure 77. Middle East and Africa Human Intestinal Organoid Culture Medium Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Human Intestinal Organoid Culture Medium Revenue (2020-2025) & (US$ Million)
Figure 82. Human Intestinal Organoid Culture Medium Industry Chain Mapping
Figure 83. Regional Human Intestinal Organoid Culture Medium Manufacturing Base Distribution (%)
Figure 84. Global Human Intestinal Organoid Culture Medium Production Market Share by Region (2020-2031)
Figure 85. Human Intestinal Organoid Culture Medium Production Process
Figure 86. Regional Human Intestinal Organoid Culture Medium Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
